• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

This paper is dedicated to the memory of our friends recently passed away, Drs Guy
Fontaine, Andrea Nava, and Nikos Protonotarios, who played a pioneering role in the …

Long COVID has become a world-wide, non-communicable epidemic, caused by long-
lasting multiorgan symptoms that endure for weeks or months after SARS-CoV-2 infection …

Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …

Background Patients with dilated cardiomyopathy whose symptoms and cardiac function
have recovered often ask whether their medications can be stopped. The safety of …

Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the
deposition of amyloid fibrils at the cardiac level. It can be due to rare genetic variants in the …

The original designation of “Arrhythmogenic right ventricular (dysplasia/) cardiomyopathy”(
ARVC) was used by the scientists who first discovered the disease, in the pre-genetic and …

The heart muscle diseases hypertrophic (HCM) and dilated (DCM) cardiomyopathies are
leading causes of sudden death and heart failure in young, otherwise healthy, individuals …

Background: Resting left ventricular outflow tract obstruction (LVOTO) occurs in 25% of
patients with hypertrophic cardiomyopathy (HCM) and is an important cause of symptoms …

Background: Cancer therapy–induced cardiomyopathy (CCM) is associated with cumulative
drug exposures and preexisting cardiovascular disorders. These parameters incompletely …